Best Practice & Research Clinical Rheumatology
Volume 22, Issue 1 , Pages 113-127, March 2008

Hypophosphatasia

  • Etienne Mornet, PhD (Assistant Professor in Genetics at the University of Versailles-Saint Quentin en Yvelines and Co-director of the SESEP laboratory (Versailles Hospital))

      Affiliations

    • Corresponding Author InformationLaboratoire SESEP, Centre Hospitalier de Versailles, Bâtiment EFS, 2 rue Jean-Louis Forain, 78150 Le Chesnay, France. Tel.: +33 1 39 63 80 13; Fax: +33 1 39 63 80 12.

Laboratoire SESEP, Centre Hospitalier de Versailles, Bâtiment EFS, 2 rue Jean-Louis Forain, 78150 Le Chesnay, France

Equipe EA2493, Université de Versailles Saint-Quentin en Yvelines, Versailles, France

Hypophosphatasia is a rare inherited disorder characterized by defective bone and tooth mineralization, and deficiency of serum and bone alkaline phosphatase activity. The frequency of the disease has been estimated to be one in 100 000 for severe forms, but mild forms of hypophosphatasia may be more common. The symptoms are highly variable in their clinical expression, which ranges from stillbirth without mineralized bone to early tooth loss without bone symptoms. The transmission of severe forms is autosomal recessive, while milder forms may be transmitted as dominant or recessive autosomal traits. The diagnosis is based on serum alkaline phosphatase assay and molecular analysis of the liver/bone/kidney alkaline phosphatase gene (ALPL). Currently, there is no treatment for the disease. Over the past 10 years, great progress has been made in understanding the structure of tissue non-specific alkaline phosphatase, its function in bone mineralization, and the effect of ALPL mutations responsible for hypophosphatasia.

Key words: hypophosphatasia, review, ALPL gene, alkaline phosphatase, bone disease, mineralization, mutations

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(07)00126-X

doi:10.1016/j.berh.2007.11.003

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 1 , Pages 113-127, March 2008